160 related articles for article (PubMed ID: 22878616)
1. Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.
Spanheimer PM; Woodfield GW; Cyr AR; Kulak MV; White-Baer LS; Bair TB; Weigel RJ
Ann Surg Oncol; 2013 Jul; 20(7):2204-12. PubMed ID: 22878616
[TBL] [Abstract][Full Text] [Related]
2. EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
De Andrade JP; Park JM; Gu VW; Woodfield GW; Kulak MV; Lorenzen AW; Wu VT; Van Dorin SE; Spanheimer PM; Weigel RJ
Mol Cancer Ther; 2016 Mar; 15(3):503-11. PubMed ID: 26832794
[TBL] [Abstract][Full Text] [Related]
3. Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling.
Liu J; Liu Z; Li M; Tang W; Pratap UP; Luo Y; Altwegg KA; Li X; Zou Y; Zhu H; Sareddy GR; Viswanadhapalli S; Vadlamudi RK
Mol Oncol; 2021 Apr; 15(4):1146-1161. PubMed ID: 33269540
[TBL] [Abstract][Full Text] [Related]
4. Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.
Spanheimer PM; Cyr AR; Gillum MP; Woodfield GW; Askeland RW; Weigel RJ
Ann Surg; 2014 Apr; 259(4):793-9. PubMed ID: 24045439
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
[TBL] [Abstract][Full Text] [Related]
6. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
Wang C; Mayer JA; Mazumdar A; Brown PH
Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
[TBL] [Abstract][Full Text] [Related]
7. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.
Woodfield GW; Chen Y; Bair TB; Domann FE; Weigel RJ
Genes Chromosomes Cancer; 2010 Oct; 49(10):948-62. PubMed ID: 20629094
[TBL] [Abstract][Full Text] [Related]
8. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
[TBL] [Abstract][Full Text] [Related]
9. High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer.
Spanheimer PM; Askeland RW; Kulak MV; Wu T; Weigel RJ
J Surg Res; 2013 Sep; 184(1):519-25. PubMed ID: 23764310
[TBL] [Abstract][Full Text] [Related]
10. Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C.
Lal G; Contreras PG; Kulak M; Woodfield G; Bair T; Domann FE; Weigel RJ
PLoS One; 2013; 8(9):e73953. PubMed ID: 24023917
[TBL] [Abstract][Full Text] [Related]
11. Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer.
Stine ZE; McGaughey DM; Bessling SL; Li S; McCallion AS
Hum Mol Genet; 2011 Oct; 20(19):3746-56. PubMed ID: 21737465
[TBL] [Abstract][Full Text] [Related]
12. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
Woodfield GW; Horan AD; Chen Y; Weigel RJ
Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
[TBL] [Abstract][Full Text] [Related]
13. TFAP2C regulates carbonic anhydrase XII in human breast cancer.
Franke CM; Gu VW; Grimm BG; Cassady VC; White JR; Weigel RJ; Kulak MV
Oncogene; 2020 Feb; 39(6):1290-1301. PubMed ID: 31636386
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.
Kona FR; Stark K; Bisoski L; Buac D; Cui Q; Dou QP
Breast Cancer Res Treat; 2012 Sep; 135(2):495-503. PubMed ID: 22850893
[TBL] [Abstract][Full Text] [Related]
15. A
Wu VT; Kiriazov B; Koch KE; Gu VW; Beck AC; Borcherding N; Li T; Addo P; Wehrspan ZJ; Zhang W; Braun TA; Brown BJ; Band V; Band H; Kulak MV; Weigel RJ
Mol Cancer Res; 2020 Jan; 18(1):46-56. PubMed ID: 31619506
[TBL] [Abstract][Full Text] [Related]
16. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.
Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH
Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells.
Fan TC; Yeo HL; Hsu HM; Yu JC; Ho MY; Lin WD; Chang NC; Yu J; Yu AL
Cancer Lett; 2018 Oct; 434():184-195. PubMed ID: 30040982
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
19. ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.
Horibata S; Rice EJ; Mukai C; Marks BA; Sams K; Zheng H; Anguish LJ; Coonrod SA; Danko CG
PLoS One; 2018; 13(4):e0194023. PubMed ID: 29608602
[TBL] [Abstract][Full Text] [Related]
20. High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer.
Kakati RT; Kim H; Whitman A; Spanheimer PM
Breast Cancer Res Treat; 2023 Jun; 199(3):589-601. PubMed ID: 37061618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
